a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.
Industry Biotechnology
A.I.dvisor tells us that OGEN and ADMA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OGEN and ADMA's prices will move in lockstep.
Ticker / NAME | Correlation To OGEN | 1D Price Change % | ||
---|---|---|---|---|
OGEN | 100% | -15.75% | ||
ADMA - OGEN | 28% Poorly correlated | -4.27% | ||
RVNC - OGEN | 27% Poorly correlated | +0.30% | ||
PTN - OGEN | 24% Poorly correlated | -7.36% | ||
GTBP - OGEN | 22% Poorly correlated | -1.40% | ||
NUVL - OGEN | 22% Poorly correlated | -1.75% | ||
More |